Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication

References

• Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev. 2004 Apr;17(2):465–93. doi: 10.1128/CMR.17.2.465-493.2004
   PubMed Web of Science ®Google Scholar
• Belsham GJ. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol. 1993;60(3):241–60. doi: 10.1016/0079-6107(93)90016-D
   PubMed Web of Science ®Google Scholar
• Gao Y, Sun SQ, Guo HC. Biological function of foot-and-mouth disease virus non-structural proteins and non-coding elements. Virol J. 2016 Jun 22;13(1):107. doi: 10.1186/s12985-016-0561-z
   PubMedGoogle Scholar
• CañCañAs-Arranz R, Forner M, Defaus S, et al. A single dose of dendrimer B2T peptide vaccine partially protects pigs against foot-and-mouth disease virus infection. Vaccines. 2020 Jan 10;8(1):19. doi: 10.3390/vaccines8010019
   Web of Science ®Google Scholar
• Lian K, Yang F, Zhu Z, et al. The VP1 S154D mutation of type Asia1 foot-and-mouth disease virus enhances viral replication and pathogenicity. Infect Genet Evol. 2016 Apr;39:113–119. doi: 10.1016/j.meegid.2016.01.009
   PubMed Web of Science ®Google Scholar
• Peng JM, Liang SM, Liang CM. VP1 of foot-and-mouth disease virus induces apoptosis via the akt signaling pathway. J Biol Chem. 2004 Dec 10;279(50):52168–74. doi: 10.1074/jbc.M403686200
   PubMed Web of Science ®Google Scholar
• Ekanayaka P, Lee SY, Herath TUB. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation. PLoS Pathog. 2020 Nov;16(11):e1009057. doi: 10.1371/journal.ppat.1009057
   PubMed Web of Science ®Google Scholar
• Hao J, Shen C, Wei N, et al. Foot-and-mouth disease virus capsid protein VP1 Antagonizes TPL2-mediated activation of the IRF3/IFN-β signaling pathway to facilitate thevirus replication. Front Immunol. 2020;11:580334. doi: 10.3389/fimmu.2020.580334
   PubMed Web of Science ®Google Scholar
• Wang S, Sun X, Yi C, et al. AGO2 negatively regulates type I interferon signaling pathway by competition binding IRF3 with CBP/p300. Front Cell Infect Microbiol. 2017;7:195. doi: 10.3389/fcimb.2017.00195
   PubMed Web of Science ®Google Scholar
• Al Hamrashdi M, Brady G. Regulation of IRF3 activation in human antiviral signaling pathways. Biochem Pharmacol. 2022 Jun;200:115026. doi: 10.1016/j.bcp.2022.115026
   PubMed Web of Science ®Google Scholar
• Webb LG, Fernandez-Sesma A. RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing. Curr Opin Virol. 2022 Apr;53:101206. doi: 10.1016/j.coviro.2022.101206
   PubMed Web of Science ®Google Scholar
• Jurczyszak D, Manganaro L, Buta S. ISG15 deficiency restricts HIV-1 infection. PLOS Pathog. 2022 Mar;18(3):e1010405. doi: 10.1371/journal.ppat.1010405
   PubMed Web of Science ®Google Scholar
• Yang C, Liu X, Cheng T. et al. LYAR suppresses beta interferon induction by targeting phosphorylated interferon regulatory factor 3. J Virol. 2019 Nov 1;93(21). doi: 10.1128/JVI.00769-19
   Web of Science ®Google Scholar
• Xie W, Tian S, Yang J, et al. OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity. Autophagy. 2022 Oct;18(10):2288–2302.
   PubMed Web of Science ®Google Scholar
• Saitoh T, Tun-Kyi A, Ryo A, et al. Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol. 2006 Jun;7(6):598–605.
   PubMed Web of Science ®Google Scholar
• Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017 Feb 2;10(1):5. doi: 10.1186/s13041-017-0287-x
   PubMedGoogle Scholar
• Prabakaran T, Bodda C, Krapp C. et al. Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J. 2018 Apr 13;37(8). doi: 10.15252/embj.201797858
   PubMed Web of Science ®Google Scholar
• Gui X, Yang H, Li T, et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019 Mar;567(7747):262–266.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mo Y, Peng M, et al. The influence of circular RNAs on autophagy and disease progression. Autophagy. 2022 Feb;18(2):240–253.
   PubMed Web of Science ®Google Scholar
• Chen X, Song X, Li J, et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy. 2023 Jan;19(1):54–74.
   PubMed Web of Science ®Google Scholar
• Wen W, Li X, Yin M, et al. Selective autophagy receptor SQSTM1/p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3. Autophagy. 2021 Nov;17(11):3763–3775.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Xu D, et al. M 6 a mRNA methylation regulates testosterone synthesis through modulating autophagy in Leydig cells. Autophagy. 2021 Feb;17(2):457–475.
   PubMed Web of Science ®Google Scholar
• Ren Z, Tang B, Xing J, et al. MTA1-mediated RNA m(6) a modification regulates autophagy and is required for infection of the rice blast fungus. New Phytol New Phytol. 2022 Jul;235(1):247–262.
   PubMed Web of Science ®Google Scholar
• Song H, Feng X, Zhang H. METTL3 and ALKBH5 oppositely regulate m 6 a modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019 Aug;15(8):1419–1437. doi: 10.1080/15548627.2019.1586246
   PubMed Web of Science ®Google Scholar
• Fang Z, Mei W, Qu C, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022 Aug 9;11(1):45. doi: 10.1186/s40164-022-00298-7
   PubMed Web of Science ®Google Scholar
• Liang D, Lin WJ. m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy. 2022 Jun;18(6):1318–1337.
   PubMed Web of Science ®Google Scholar
• Geng S, Zheng W, Wang W. The m6A reader YTHDF2 modulates antiviral and antibacterial activity by suppressing METTL3 methylation-modified STING in fish. J Immunol. 2023 Mar 1;210(5):653–667. doi: 10.4049/jimmunol.2200618
   PubMed Web of Science ®Google Scholar
• Liu WB, Jia WD, Ma JL, et al. Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance. Oncotarget. 2017 Nov 7;8(55):93984–93997. doi: 10.18632/oncotarget.21500
   PubMedGoogle Scholar
• Zhou Q, Yin Y, Yu M, et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 2022 Oct;56:102458. doi: 10.1016/j.redox.2022.102458
   PubMed Web of Science ®Google Scholar
• Wu J, Chen G, Wang W. GTPBP4: a new therapeutic target gene promotes tumor progression in non-small cell lung cancer via EMT. J Oncol. 2022;2022:1–11. doi: 10.1155/2022/2164897
   Web of Science ®Google Scholar
• Hu Y, Xie J, Chen L, et al. Integrated analysis of genomic and transcriptomic profiles identified the role of GTP binding protein-4 (GTPBP4) in breast cancer. Front Pharmacol. 2022;13:880445. doi: 10.3389/fphar.2022.880445
   PubMed Web of Science ®Google Scholar
• Chouchana L, Fernández-Ramos AA, Dumont F, et al. Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines. Genome Med. 2015;7(1):37. doi: 10.1186/s13073-015-0150-6
   PubMedGoogle Scholar
• Jensen BC, Wang Q, Kifer CT, et al. The NOG1 GTP-binding protein is required for biogenesis of the 60 S ribosomal subunit. J Biol Chem. 2003 Aug 22;278(34):32204–11. doi: 10.1074/jbc.M304198200
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang Z, Huang M. Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflamm. 2020;2020:9273241. doi: 10.1155/2020/9273241
   PubMed Web of Science ®Google Scholar
• Lin Y, Wu C, Wang X, et al. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Autophagy. 2020 Mar;16(3):548–561.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang F, Li K, et al. The insufficient activation of RIG-I-Like signaling pathway contributes to highly efficient replication of porcine picornaviruses in IBRS-2 cells. Mol Cell Proteomics. 2021;20:100147. doi: 10.1016/j.mcpro.2021.100147
   PubMed Web of Science ®Google Scholar
• Wang D, Fang L, Liu L, et al. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway. Mol Immunol. 2011 Oct;49(1–2):407–12.
   PubMed Web of Science ®Google Scholar
• Klingauf-Nerurkar P, Gillet LC, Portugal-Calisto D. The GTPase Nog1 co-ordinates the assembly, maturation and quality control of distant ribosomal functional centers. Elife. 2020 Jan 7;9.
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. Irfs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006 Sep;6(9):644–58. doi: 10.1038/nri1900
   PubMed Web of Science ®Google Scholar
• Manivanh R, Mehrbach J, Knipe DM. et al. Role of herpes simplex virus 1 γ34.5 in the regulation of IRF3 signaling. J Virol. 2017 Dec 1;91(23). doi: 10.1128/JVI.01156-17
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu Z, Feng T, et al. African swine fever virus E120R protein inhibits interferon beta production by interacting with IRF3 to block its activation. J Virol. 2021 Aug 25;95(18):e0082421. doi: 10.1128/JVI.00824-21
   PubMed Web of Science ®Google Scholar
• Hou G, Zhao X, Li L, et al. Sumoylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRnas. Nucleic Acids Res. 2021 Mar 18;49(5):2859–2877. doi: 10.1093/nar/gkab065
   PubMed Web of Science ®Google Scholar
• Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat Commun. 2016 Aug 25;7(1):12626. doi: 10.1038/ncomms12626
   PubMedGoogle Scholar
• Chen X, Zhou X, Wang X. m6A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022 Apr 5;11(1):21. doi: 10.1186/s40164-022-00269-y
   PubMed Web of Science ®Google Scholar
• Kong N, Shan T, Wang H, et al. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy. Autophagy. 2020 Oct;16(10):1737–1752.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu X, Wang H, et al. HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation. Autophagy. 2021 Aug;17(8):1962–1977.
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010 May;221(1):3–12. doi: 10.1002/path.2697
   PubMed Web of Science ®Google Scholar
• Zhu Z, Yang C, Iyaswamy A, et al. Balancing mTOR signaling and autophagy in the treatment of Parkinson’s disease. Int J Mol Sci. 2019 Feb 8;20(3):728. doi: 10.3390/ijms20030728
   PubMed Web of Science ®Google Scholar
• Rabanal-Ruiz Y, Otten EG, Korolchuk VI, et al. mTORC1 as the main gateway to autophagy. Essays Biochem. 2017 Dec 12;61(6):565–584. doi: 10.1042/EBC20170027
   PubMed Web of Science ®Google Scholar
• Ming SL, Zhang S, Wang Q, et al. Inhibition of USP14 influences alphaherpesvirus proliferation by degrading viral VP16 protein via ER stress-triggered selective autophagy. Autophagy. 2022 Aug;18(8):1801–1821.
   PubMed Web of Science ®Google Scholar
• Kotecha A, Seago J, Scott K, et al. Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol. 2015 Oct;22(10):788–94.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Qu M, et al. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. Autophagy. 2023 Nov;19(11):2869–2883.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Mao J, et al. Determining the clinical value and critical pathway of GTPBP4 in lung adenocarcinoma using a bioinformatics strategy: a study based on datasets from the cancer genome atlas. Biomed Res Int. 2020;2020:1–13. doi: 10.1155/2020/5171242
   Web of Science ®Google Scholar
• Li L, Pang X, Zhu Z, et al. GTPBP4 promotes gastric cancer progression via regulating P53 activity. Cell Physiol Biochem. 2018;45(2):667–676. doi: 10.1159/000487160
   PubMedGoogle Scholar
• Zhang N, Shen H, Huang S, et al. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma. Eur J Histochem. 2021 Nov 16;65(4). doi: 10.4081/ejh.2021.3300
   Web of Science ®Google Scholar
• Oduro PK, Zheng X, Wei J, et al. The cGAS–STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022 Jan;12(1):50–75.
   PubMed Web of Science ®Google Scholar
• Deater M, Tamhankar M, Lloyd RE. TDRD3 is an antiviral restriction factor that promotes IFN signaling with G3BP1. PLoS Pathog. 2022 Jan;18(1):e1010249. doi: 10.1371/journal.ppat.1010249
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang Q, Yang F, et al. JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination. PLoS Pathog. 2021 Mar;17(3):e1009366.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Cheng X, Sun Z, et al. Grass carp PRMT6 negatively regulates innate immunity by inhibiting the TBK1/IRF3 binding and cutting down IRF3 phosphorylation level. Dev Comp Immunol. 2022 Apr;129:104351. doi: 10.1016/j.dci.2022.104351
   PubMed Web of Science ®Google Scholar
• Jennings S, Martínez-Sobrido L, García-Sastre A, et al. Thogoto virus ML protein suppresses IRF3 function. Virology. 2005 Jan 5;331(1):63–72. doi: 10.1016/j.virol.2004.10.015
   PubMed Web of Science ®Google Scholar
• Basler CF, Mikulasova A, Martinez-Sobrido L, et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 2003 Jul;77(14):7945–56.
   PubMed Web of Science ®Google Scholar
• Xue Q, Liu H, Zhu Z, et al. Seneca Valley virus 3Cpro abrogates the IRF3- and IRF7-mediated innate immune response by degrading IRF3 and IRF7. Virology. 2018 May;518:1–7. doi: 10.1016/j.virol.2018.01.028
   PubMed Web of Science ®Google Scholar
• Zhang W, Yang F, Zhu Z. et al. Cellular DNAJA3, a novel VP1-interacting protein, inhibits foot-and-mouth disease virus replication by inducing lysosomal degradation of VP1 and attenuating its antagonistic role in the beta interferon signaling pathway. J Virol. 2019 Jul 1;93(13). doi: 10.1128/JVI.00588-19
   Web of Science ®Google Scholar
• Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Bio. 2021 Mar 16;22(1):85. doi: 10.1186/s13059-021-02308-z
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhao Y, Liu Q, et al. DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus. Microbiol Spectr. 2022 Jun 29;10(3):e0109822. doi: 10.1128/spectrum.01098-22
   PubMed Web of Science ®Google Scholar
• Huang CS, Zhu YQ, Xu QC, et al. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation. Clin Transl Med. 2022 Jun;12(6):e848.
   PubMed Web of Science ®Google Scholar
• Chai RC, Chang YZ, Chang X, et al. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma. J Hematol Oncol. 2021 Jul 10;14(1):109. doi: 10.1186/s13045-021-01124-z
   PubMed Web of Science ®Google Scholar
• Zhong L, Liao D, Zhang M, et al. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Lett. 2019 Feb 1;442:252–261. doi: 10.1016/j.canlet.2018.11.006
   PubMed Web of Science ®Google Scholar
• Zhu Z, Li C, Du X, et al. Foot-and-mouth disease virus infection inhibits LGP2 protein expression to exaggerate inflammatory response and promote viral replication. Cell Death Dis. 2017 Apr 13;8(4):e2747. doi: 10.1038/cddis.2017.170
   PubMedGoogle Scholar
• Liu H, Zhu Z, Xue Q. et al. Foot-and-mouth disease virus antagonizes NOD2-mediated antiviral effects by inhibiting NOD2 protein expression. J Virol. 2019 Jun 1;93(11). doi: 10.1128/JVI.00124-19
   Web of Science ®Google Scholar
• Liu H, Xue Q, Zhu Z, et al. Foot-and-mouth disease virus inhibits RIP2 protein expression to promote viral replication. Virol Sin. 2021 Aug;36(4):608–622.
   PubMed Web of Science ®Google Scholar
• Kirkin V, McEwan DG, Novak I, et al. A role for ubiquitin in selective autophagy. Molecular Cell. 2009 May 15;34(3):259–69. doi: 10.1016/j.molcel.2009.04.026
   PubMed Web of Science ®Google Scholar
• Jin S, Tian S, Luo M, et al. Tetherin suppresses type I interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells. Molecular Cell. 2017 Oct 19;68(2):308–322.e4. doi: 10.1016/j.molcel.2017.09.005
   PubMed Web of Science ®Google Scholar
• Gong Y, Tang N, Liu P, et al. Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells. Autophagy. 2022 Jul;18(7):1503–1521.
   PubMed Web of Science ®Google Scholar
• Hou P, Wang X, Wang H, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy. 2023 Feb;19(2):551–569.
   PubMed Web of Science ®Google Scholar
• Sun D, Kong N, Dong S, et al. 2AB protein of senecavirus a antagonizes selective autophagy and type I interferon production by degrading LC3 and MARCHF8. Autophagy. 2022 Aug;18(8):1969–1981.
   PubMed Web of Science ®Google Scholar
• Sun P, Zhang S, Qin X, et al. Foot-and-mouth disease virus capsid protein VP2 activates the cellular EIF2S1-ATF4 pathway and induces autophagy via HSPB1. Autophagy. 2018;14(2):336–346. doi: 10.1080/15548627.2017.1405187
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Qu M, et al. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. Autophagy. 2023 Jul;14(11):1–15.
   Google Scholar
• Liu H, Zhu Z, Xue Q, et al. Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication. PLoS Pathogens. 2023 Feb 3;19(2):e1011126. doi: 10.1371/journal.ppat.1011126
   PubMed Web of Science ®Google Scholar
• Chen H, Humes ST, Rose M, et al. Hydroxyl functionalized multi-walled carbon nanotubes modulate immune responses without increasing 2009 pandemic influenza A/H1N1 virus titers in infected mice. Toxicol Appl Pharmacol. 2020 Oct 1;404:115167. doi: 10.1016/j.taap.2020.115167
   PubMed Web of Science ®Google Scholar
• Huang ML, Chiang PS, Luo ST, et al. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. J Virol Methods. 2010 Apr;165(1):42–5.
   PubMed Web of Science ®Google Scholar
• Zhang S, Hu B, Xu J, et al. Influenza A virus infection induces liver injury in mice. Microbial Pathogenesis. 2019 Dec;137:103736. doi: 10.1016/j.micpath.2019.103736
   PubMed Web of Science ®Google Scholar
• Fensterl V, Wetzel JL, Ramachandran S, et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathogens. 2012;8(5):e1002712. doi: 10.1371/journal.ppat.1002712
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu Z, Xue Q, et al. Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release. PLoS Pathog. 2023 Feb;19(2):e1011132.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Xu Y, Zhang Y, et al. Human virus-derived small RNAs can confer antiviral immunity in mammals. Immunity. 2017 Jun 20;46(6):992–1004.e5. doi: 10.1016/j.immuni.2017.05.006
   PubMed Web of Science ®Google Scholar
• Cresta D, Warren DC, Quirouette C, et al. Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample’s infection concentration. PLoS Comput Biol. 2021 Oct 18;17(10):e1009480. doi: 10.1371/journal.pcbi.1009480
   PubMed Web of Science ®Google Scholar
• Xue Q, Zhu Z, Xue Z, et al. NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLoS Pathogens. 2023 Jul;19(7):e1011511.
   PubMed Web of Science ®Google Scholar
• Li D, Yang W, Yang F, et al. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway. FASEB J. 2016 May;30(5):1757–1766.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. 10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Jin J, Xu Y, Huo L, et al. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue. PloS One. 2020;15(2):e0228910. doi: 10.1371/journal.pone.0228910
   PubMed Web of Science ®Google Scholar
• Liu H, Xue Q, Cao W, et al. Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication. FASEB J. 2018 Jun 15;32(12):6706–6723. doi: 10.1096/fj.201701351
   Web of Science ®Google Scholar
• Li X, Guo G, Lu M. et al. Long noncoding RNA lnc-MxA inhibits beta interferon transcription by forming RNA-DNA triplexes at its promoter. J Virol. 2019 Nov 1;93(21). doi: 10.1128/JVI.00786-19
   Web of Science ®Google Scholar
• Li M, Jiang X, Liu D, et al. Autophagy protects LNCaP cells under androgen deprivation conditions. Autophagy. 2008 Jan;4(1):54–60.
   PubMed Web of Science ®Google Scholar